Legal Representation
Attorney
Scott D. Marty, J.D., Ph.D.
USPTO Deadlines
Next Deadline
200 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200818)
Due Date
August 18, 2026
Grace Period Ends
February 18, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
27 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 18, 2025 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jul 23, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 23, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 23, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 23, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jul 23, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Aug 18, 2020 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 2, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 2, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 13, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 23, 2020 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 8, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 7, 2020 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Nov 19, 2019 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 19, 2019 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Nov 19, 2019 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 18, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 18, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 17, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 14, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 13, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 13, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 13, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 20, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Mar 4, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemicals for use in manufacturing pharmaceuticals; chemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals
Class 005
Pharmaceuticals for the treatment of cancer; pharmaceutical compositions for the treatment of cancer; pharmaceutical drugs for the treatment of cancer; anti-cancer preparations; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations for human use for suppressing tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology
Class 042
Scientific research; medical research services; pharmaceutical research services; pharmaceutical products development; pharmaceutical research and development
Classification
International Classes
001
005
042